Last reviewed · How we verify
NCT05242913
Effects of Resistant Potato Starch on the Gut Microbiota
NA trial testing Resistant Potato Starch in Microbiota in 75 participants. Completed in 6 January 2020.
6 January 2020
Quick facts
| Lead sponsor | MSP Starch Products Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 75 |
| Start date | 30 October 2019 |
| Primary completion | 6 January 2020 |
| Estimated completion | 6 January 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Resistant Potato Starch — full drug profile →
- Placebo
Conditions studied
- Microbiota — all drugs for Microbiota →
Sponsor
MSP Starch Products Inc.
Who can join
Adults 18 to 69, any sex, with Microbiota. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This was a randomized, double-blind, three-arm, parallel group clinical trial, which assessed the shifts that occur in microbial populations after four weeks of supplementation with resistant potato starch (SolnulTM) at two different dosages, in comparison to a placebo in healthy adults.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Consumption of Solnul<sup>™</sup> Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial.
Bush JR, Baisley J, Harding SV, Alfa MJ. · · 2023 · cited 10× · PMID 37049425 · DOI 10.3390/nu15071582 -
Resistant Potato Starch Supplementation Reduces Serum Free Fatty Acid Levels and Influences Bile Acid Metabolism.
Bush JR, Iwuamadi I, Han J, Schibli DJ, et al · · 2024 · cited 5× · PMID 39452917 · DOI 10.3390/metabo14100536 -
Consumption of resistant potato starch produces changes in gut microbiota that correlate with improvements in abnormal bowel symptoms: a secondary analysis of a clinical trial.
Bush JR, Alfa MJ. · · 2024 · cited 4× · PMID 39605008 · DOI 10.1186/s40795-024-00962-7 -
Resistant Potato Starch Supplementation Increases the Serum Levels of Choline and Sphingomyelins Without Affecting Trimethylamine Oxide Levels.
Bush JR, Han J, Goodlett DR. · · 2025 · cited 1× · PMID 41149640 · DOI 10.3390/metabo15100662 -
Resistant Potato Starch Supplementation Increases Serum Antioxidant Levels in a Randomized Trial.
Bush JR, Han J, Goodlett DR. · · 2025 · cited 1× · PMID 41149639 · DOI 10.3390/metabo15100661
Verify or expand the search:
- PubMed search for NCT05242913
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Resistant Potato Starch
Trials testing the same drug.
- NCT06949631 — Study on the Effects of Resistant Potato Starch on Gut Bacteria in Healthy Adults · NA · completed
- NCT05820893 — Resistant Potato Starch to Alleviate GWI · Phase 2 · recruiting
- NCT06425380 — Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy · NA · recruiting
Other recruiting trials for Microbiota
Currently open trials in the same condition.
- NCT07479511 — Adaptation of Lung Transplant Recipients at Extreme Altitude · active not recruiting
- NCT07212361 — Infant Microbiota Restoration With Maternal Microbes · NA · recruiting
- NCT07029360 — Effectiveness of Coenzyme Q10 and Probiotics in Periodontal Therapy During Pregnancy · NA · recruiting
- NCT06809660 — Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (P · NA · recruiting
- NCT07154173 — Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer · recruiting
Other MSP Starch Products Inc. trials
Trials by the same sponsor.
- NCT06949631 — Study on the Effects of Resistant Potato Starch on Gut Bacteria in Healthy Adults · NA · completed
- NCT03910153 — Effect of MSPrebiotic on Gastrointestinal Function and Blood Glucose Levels · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05242913 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MSP Starch Products Inc.
- Last refreshed: 16 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05242913.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing